Researchers find breast cancer protein that could predict chemotherapy sensitivity

by Hunter Medical Research InstituteThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: NCI Center for

Updated on: February 20,2024

Researchers find breast cancer protein that could predict chemotherapy sensitivity

by Hunter Medical Research InstituteThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: NCI Center for

Updated on:February 20,2024

How do we overcome treatment resistance in a sarcoma cancer with already limited treatment options?

by Elena Daviter-Nowell,Institute of Cancer ResearchHistopathology image of leiomyosarcoma. Credit:Wikimedia Commons, CC-BY-SA 4.0Leiomyosarcoma is a type of soft tissue sarcoma that is ha

Updated on: January 10,2024

How do we overcome treatment resistance in a sarcoma cancer with already limited treatment options?

by Elena Daviter-Nowell,Institute of Cancer ResearchHistopathology image of leiomyosarcoma. Credit:Wikimedia Commons, CC-BY-SA 4.0Leiomyosarcoma is a type of soft tissue sarcoma that is ha

Updated on:January 10,2024

Could artificial sweeteners alter your microbiome?

by Dennis ThompsonYou may think that artificial sweeteners can help you lose some weight, but a new study finds they are no good for your gut's microbiome.People who useaspartame(Equal

Updated on: May 06,2024

Could artificial sweeteners alter your microbiome?

by Dennis ThompsonYou may think that artificial sweeteners can help you lose some weight, but a new study finds they are no good for your gut's microbiome.People who useaspartame(Equal

Updated on:May 06,2024

Disorderly DNA helps cancer cells evade treatment

byNorthwestern UniversityWhen the chromatin packing is heterogenous and disordered, a cell demonstrates more plasticity. Credit: Northwestern UniversityEach cell in the human body holds a full t

Updated on: December 22,2023

Disorderly DNA helps cancer cells evade treatment

byNorthwestern UniversityWhen the chromatin packing is heterogenous and disordered, a cell demonstrates more plasticity. Credit: Northwestern UniversityEach cell in the human body holds a full t

Updated on:December 22,2023

Access to high-cost targeted treatments varies for lung cancer

(HealthDay)—Not all patients have access to new, high-cost lung cancer drugs, according to a study recently published in theJournal of the National Cancer Institute.Cathy J. Bradley, Ph.D., from

Updated on: December 22,2023

Access to high-cost targeted treatments varies for lung cancer

(HealthDay)—Not all patients have access to new, high-cost lung cancer drugs, according to a study recently published in theJournal of the National Cancer Institute.Cathy J. Bradley, Ph.D., from

Updated on:December 22,2023

Body fat percentage vs. BMI: Which is important?

by Taylor Barnes,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainThe start of a new year for many means the start of a new health and fitness journey. Claire Edgemon, senior registere

Updated on: May 06,2024

Body fat percentage vs. BMI: Which is important?

by Taylor Barnes,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainThe start of a new year for many means the start of a new health and fitness journey. Claire Edgemon, senior registere

Updated on:May 06,2024

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

Updated on: April 28,2024

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

Updated on:April 28,2024

Discovery unveils promising anticancer drug targeting KRAS protein

byVirginia Commonwealth UniversityKRB-456 inhibits the growth in vivo of orthotopic mt KRAS tumors derived from pancreatic cancer patients. Tumor biopsies from pancreatic cancer patient G160 wer

Updated on: December 30,2023

Discovery unveils promising anticancer drug targeting KRAS protein

byVirginia Commonwealth UniversityKRB-456 inhibits the growth in vivo of orthotopic mt KRAS tumors derived from pancreatic cancer patients. Tumor biopsies from pancreatic cancer patient G160 wer

Updated on:December 30,2023

Recent screening rose among people under 50 after release of new colorectal guidelines

byAmerican Cancer SocietyCredit: CC0 Public DomainRecent colorectal cancer screening rates more than doubled among people ages 45 to 49 in the months after the release of updated American Cancer

Updated on: December 22,2023

Recent screening rose among people under 50 after release of new colorectal guidelines

byAmerican Cancer SocietyCredit: CC0 Public DomainRecent colorectal cancer screening rates more than doubled among people ages 45 to 49 in the months after the release of updated American Cancer

Updated on:December 22,2023

Surgery first for colon cancer? Not so fast, according to new study

by National Comprehensive Cancer NetworkRadiologic response, TRG, and clinical T stage. (A) Radiologic response among patients with different clinical T stage; patients with cT2–3 disease were more li

Updated on: January 10,2024

Surgery first for colon cancer? Not so fast, according to new study

by National Comprehensive Cancer NetworkRadiologic response, TRG, and clinical T stage. (A) Radiologic response among patients with different clinical T stage; patients with cT2–3 disease were more li

Updated on:January 10,2024

Researchers identify protein with DYRK1A-inhibiting effect that may have implications for Down syndrome

by Kyoto UniversityDYRK1A bound to FAM53C in the cytoplasm is less active. DYRK1A not bound to FAM53C in the nucleus is highly active. Functional abnormalities cause various neuropsychiatric deve

Updated on: February 20,2024

Researchers identify protein with DYRK1A-inhibiting effect that may have implications for Down syndrome

by Kyoto UniversityDYRK1A bound to FAM53C in the cytoplasm is less active. DYRK1A not bound to FAM53C in the nucleus is highly active. Functional abnormalities cause various neuropsychiatric deve

Updated on:February 20,2024

Uptake of HIV prevention medication doubles with mix of digital health interventions, study finds

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA UCLA Health-led study found a combination of interventions of one-on-one telehealth coaching, peer support forums, and a

Updated on: May 16,2024

Uptake of HIV prevention medication doubles with mix of digital health interventions, study finds

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA UCLA Health-led study found a combination of interventions of one-on-one telehealth coaching, peer support forums, and a

Updated on:May 16,2024